Givaudan | GIVN - Selling And Administration Expenses

Stock Price
2,700.00
Daily Change
17.00 0.63%
Monthly
-6.15%
Yearly
-33.99%
Q2 Forecast
2,724.25

Givaudan reported CHF561M in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Air Liquide EUR 2.57B 1.27B Dec/2024
Akzo Nobel EUR 804M 7M Mar/2026
Anheuser-Busch USD 4.74B 43M Mar/2026
Arkema EUR 228.6M 15.6M Mar/2026
BASF EUR 2.13B 84M Mar/2026
Bayer EUR 3.7B 356M Mar/2026
Beiersdorf EUR 271M 51M Dec/2025
British American Tobacco GBP 687.5M 611.5M Jun/2024
Covestro EUR 445M 8M Dec/2025
Danone EUR 4.7B 170M Dec/2025
Diageo GBP 1.7B 63M Dec/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 749M 36M Mar/2026
Givaudan CHF 561M 25M Dec/2025
Heineken EUR 1.1B 52M Jun/2025
Henkel EUR 3.49B 38M Dec/2025
International Flavors Fragrances USD 427M 42M Mar/2026
Johnson Matthey GBP 170M 87M Dec/2025
L'Oréal EUR 4.1B 95.5M Dec/2025
Merck EUR 1.6B 136M Dec/2025
Nestle CHF 12.46B 267M Dec/2025
Pernod Ricard EUR 799M 156M Dec/2025
SGS CHF 3M 1.7B Dec/2024
Solvay EUR 131M 24M Mar/2026
Victrex GBP 32M 2.7M Jun/2026